Abstract: The present invention provides an ophthalmic composition containing xanthan gum, or xanthan gum and an amino acid, which has a superior corneal epithelial disorder-treating effect and a superior corneal epithelial cell-protecting effect.

Abstract: The present invention provides an ophthalmic composition containing xanthan gum, or xanthan gum and an amino acid, which has a superior corneal epithelial disorder-treating effect and a superior corneal epithelial cell-protecting effect.

Abstract: The present invention provides an ophthalmic composition containing xanthan gum, or xanthan gum and an amino acid, which has a superior corneal epithelial disorder-treating effect and a superior corneal epithelial cell-protecting effect.

Abstract: The present invention provides an ophthalmic composition containing xanthan gum and glucose, which has a superior corneal epithelial disorder-treating effect.

Abstract: The present invention provides an ophthalmic composition containing xanthan gum, or xanthan gum and an amino acid, which has a superior corneal epithelial disorder-treating effect and a superior corneal epithelial cell-protecting effect.

Abstract: The present invention provides an ophthalmic composition containing xanthan gum and glucose, which has a superior corneal epithelial disorder-treating effect.

Abstract: The present invention provides an ophthalmic composition containing xanthan gum, or xanthan gum and an amino acid, which has a superior corneal epithelial disorder-treating effect and a superior corneal epithelial cell-protecting effect.

Abstract: A type of eye drops, characterized in that it comprises ginger perfume as a refrigerant.

Abstract: The present invention provides an agent for contact lenses, which contains an oxo-acid compound and/or a polyacid compound. The agent for contact lenses of the present invention can remove protein as, for example, a protein remover, irrespective of the kind of contact lens and without using a special cleaning device. In addition, washing with water after protein removal is not necessary.

Abstract: The present invention provides an agent for contact lenses, which contains an oxo-acid compound and/or a polyacid compound. The agent for contact lenses of the present invention can remove protein as, for example, a protein remover, irrespective of the kind of contact lens and without using a special cleaning device. In addition, washing with water after protein removal is not necessary.

Abstract: A method to substantially eliminate irritativeness caused by surface active agents contained in an aqueous composition is provided. The method employs, in the production of said composition, in combination one or more surface active agents having an anionic active group with one or more nonionic surface active agents, with a mutual ratio of said one or more surface active agents having an anionic active group to said one or more nonionic surface active agents being 1:1 to 1:6 in concentration by weight. Aqueous compositions with reduced irritativeness as well as a method of solubilization of an insoluble or scarcely soluble pharmaceutical ingredient in producing an external-use aqueous pharmaceutical preparation are also provided.

Abstract: An aqueous pharmaceutical preparation is provided containing chloride ion and stably containing chlorhexidine gluconate, characterized in that said preparation further contains at least one pharmaceutically acceptable polycarboxylic acid of the formula I:HOOC--(CR.sub.i 1 --CR.sub.i 2)n --COOH (I)wherein n is an integer 1, 2 or 3; i is a positive integer not more than n; R.sup.11 and R.sub.12, when n=1, independently from each other, are H, --OH or --COOH; each of R.sub.11, R.sub.12, R.sub.21 and R.sub.22, when n=2, is H, --OH or --COOH, but not all of them are H simultaneously; and each of R.sub.11, R.sub.12, R.sub.21, R.sub.22, R.sub.31 and R.sub.32, when n=3, is H, --OH or --COOH, but two adjacent carbons in no case contain four hydrogen atoms in total; or a pharmaceutically acceptable salt thereof.